Literature DB >> 32104571

Donor-Specific Antibodies in Liver Transplantation.

Kathy M Nilles1, Josh Levitsky1.   

Abstract

http://aasldpubs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2046-2484/video/15-1-reading-nilles a video presentation of this article Answer questions and earn https://www.wileyhealthlearning.com/Activity/7025330/disclaimerspopup.aspx.
© 2020 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2020        PMID： 32104571      PMCID： PMC7041955          DOI： 10.1002/cld.871

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


  11 in total

Review 1.  Prevention and treatment of liver allograft antibody-mediated rejection and the role of the 'two-hit hypothesis'.

Authors:  Peter T W Kim; Anthony J Demetris; Jacqueline G O'Leary
Journal:  Curr Opin Organ Transplant       Date:  2016-04       Impact factor: 2.640

2.  High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplant.

Authors:  J G O'Leary; H Kaneku; B M Susskind; L W Jennings; M A Neri; G L Davis; G B Klintmalm; P I Terasaki
Journal:  Am J Transplant       Date:  2011-06-14       Impact factor: 8.086

3.  2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection.

Authors:  A J Demetris; C Bellamy; S G Hübscher; J O'Leary; P S Randhawa; S Feng; D Neil; R B Colvin; G McCaughan; J J Fung; A Del Bello; F P Reinholt; H Haga; O Adeyi; A J Czaja; T Schiano; M I Fiel; M L Smith; M Sebagh; R Y Tanigawa; F Yilmaz; G Alexander; L Baiocchi; M Balasubramanian; I Batal; A K Bhan; J Bucuvalas; C T S Cerski; F Charlotte; M E de Vera; M ElMonayeri; P Fontes; E E Furth; A S H Gouw; S Hafezi-Bakhtiari; J Hart; E Honsova; W Ismail; T Itoh; N C Jhala; U Khettry; G B Klintmalm; S Knechtle; T Koshiba; T Kozlowski; C R Lassman; J Lerut; J Levitsky; L Licini; R Liotta; G Mazariegos; M I Minervini; J Misdraji; T Mohanakumar; J Mölne; I Nasser; J Neuberger; M O'Neil; O Pappo; L Petrovic; P Ruiz; Ö Sağol; A Sanchez Fueyo; E Sasatomi; A Shaked; M Shiller; T Shimizu; B Sis; A Sonzogni; H L Stevenson; S N Thung; G Tisone; A C Tsamandas; A Wernerson; T Wu; A Zeevi; Y Zen
Journal:  Am J Transplant       Date:  2016-07-14       Impact factor: 8.086

4.  Liver allograft antibody-mediated rejection with demonstration of sinusoidal C4d staining and circulating donor-specific antibodies.

Authors:  Tomasz Kozlowski; Tara Rubinas; Volker Nickeleit; John Woosley; John Schmitz; Dana Collins; Paul Hayashi; Anthony Passannante; Kenneth Andreoni
Journal:  Liver Transpl       Date:  2011-04       Impact factor: 5.799

5.  The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.

Authors:  A I Musat; R M Agni; P Y Wai; J D Pirsch; D F Lorentzen; A Powell; G E Leverson; J M Bellingham; L A Fernandez; D P Foley; J D Mezrich; A M D'Alessandro; M R Lucey
Journal:  Am J Transplant       Date:  2011-03       Impact factor: 8.086

6.  Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report.

Authors:  Anat R Tambur; Patricia Campbell; Frans H Claas; Sandy Feng; Howard M Gebel; Annette M Jackson; Roslyn B Mannon; Elaine F Reed; Kathryn Tinckam; Medhat Askar; Anil Chandraker; Patricia P Chang; Monica Colvin; Anthony-Jake Demetris; Joshua M Diamond; Anne I Dipchand; Robert L Fairchild; Mandy L Ford; John Friedewald; Ronald G Gill; Denis Glotz; Hilary Goldberg; Ramsey Hachem; Stuart Knechtle; Jon Kobashigawa; Deborah J Levine; Joshua Levitsky; Michael Mengel; Edgar Milford; Kenneth A Newell; Jacqueline G O'Leary; Scott Palmer; Parmjeet Randhawa; John Smith; Laurie Snyder; Randall C Starling; Stuart Sweet; Timucin Taner; Craig J Taylor; Steve Woodle; Adriana Zeevi; Peter Nickerson
Journal:  Am J Transplant       Date:  2018-05-22       Impact factor: 8.086

7.  Donor-Specific HLA Antibodies in Living Versus Deceased Donor Liver Transplant Recipients.

Authors:  J Levitsky; H Kaneku; C Jie; R C Walsh; M Abecassis; A R Tambur
Journal:  Am J Transplant       Date:  2016-03-23       Impact factor: 8.086

8.  Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation.

Authors:  J G O'Leary; H Kaneku; N Banuelos; L W Jennings; G B Klintmalm; P I Terasaki
Journal:  Am J Transplant       Date:  2015-03-13       Impact factor: 8.086

9.  De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients.

Authors:  H Kaneku; J G O'Leary; N Banuelos; L W Jennings; B M Susskind; G B Klintmalm; P I Terasaki
Journal:  Am J Transplant       Date:  2013-06       Impact factor: 8.086

10.  Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation.

Authors:  Jacqueline G O'Leary; Hugo Kaneku; Linda W Jennings; Nubia Bañuelos; Brian M Susskind; Paul I Terasaki; Göran B Klintmalm
Journal:  Liver Transpl       Date:  2013-07-26       Impact factor: 5.799
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.